Pneumococcal 23-polyvalent vaccine Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with pneumococcal 23-polyvalent vaccine
K
- Kanjinti (trastuzumab)
- Ken-Jec 40 (triamcinolone)
- Kenaject-40 (triamcinolone)
- Kenalog-10 (triamcinolone)
- Kenalog-40 (triamcinolone)
- Kesimpta (ofatumumab)
- Kevzara (sarilumab)
- Key-Pred (prednisolone)
- Key-Pred SP (prednisolone)
- Kineret (anakinra)
- Kisqali (ribociclib)
- Kisqali Femara Co-Pack (letrozole / ribociclib)
- Kymriah (tisagenlecleucel)
- Kyprolis (carfilzomib)
More about pneumococcal 23-polyvalent vaccine
- pneumococcal 23-polyvalent vaccine consumer information
- Check interactions
- Compare alternatives
- Reviews (18)
- Side effects
- Dosage information
- During pregnancy
- Drug class: bacterial vaccines
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.